Hedge funds sold Moderna, BioNtech shares before vaccine news

(Reuters) – A number of hedge funds sold positions in two drug companies leading the race to a coronavirus vaccine in the quarter before both announced breakthroughs that lifted their stock prices, while a few took stakes in the companies during that time.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Comments are closed.